470 related articles for article (PubMed ID: 21777703)
1. B-cells and their targeting in rheumatoid arthritis--current concepts and future perspectives.
Nakken B; Munthe LA; Konttinen YT; Sandberg AK; Szekanecz Z; Alex P; Szodoray P
Autoimmun Rev; 2011 Nov; 11(1):28-34. PubMed ID: 21777703
[TBL] [Abstract][Full Text] [Related]
2. Morphological and molecular pathology of the B cell response in synovitis of rheumatoid arthritis.
Magalhães R; Stiehl P; Morawietz L; Berek C; Krenn V
Virchows Arch; 2002 Nov; 441(5):415-27. PubMed ID: 12447670
[TBL] [Abstract][Full Text] [Related]
3. Synovial infiltration with CD79a-positive B cells, but not other B cell lineage markers, correlates with joint destruction in rheumatoid arthritis.
Mo YQ; Dai L; Zheng DH; Zhu LJ; Wei XN; Pessler F; Shen J; Zhang BY
J Rheumatol; 2011 Nov; 38(11):2301-8. PubMed ID: 22002013
[TBL] [Abstract][Full Text] [Related]
4. Crossroads of B cell activation in autoimmunity: rationale of targeting B cells.
Dörner T
J Rheumatol Suppl; 2006 May; 77():3-11. PubMed ID: 16652439
[TBL] [Abstract][Full Text] [Related]
5. Immunopathologic role of B lymphocytes in rheumatoid arthritis: rationale of B cell-directed therapy.
Martinez-Gamboa L; Brezinschek HP; Burmester GR; Dörner T
Autoimmun Rev; 2006 Aug; 5(7):437-42. PubMed ID: 16920569
[TBL] [Abstract][Full Text] [Related]
6. Immunohistochemical analysis as a means to predict responsiveness to rituximab treatment.
Teng YK; Levarht EW; Hashemi M; Bajema IM; Toes RE; Huizinga TW; van Laar JM
Arthritis Rheum; 2007 Dec; 56(12):3909-18. PubMed ID: 18050222
[TBL] [Abstract][Full Text] [Related]
7. B cell-directed therapy in rheumatoid arthritis--clinical experience.
Panayi GS
J Rheumatol Suppl; 2005 Feb; 73():19-24; discussion 29-30. PubMed ID: 15693112
[TBL] [Abstract][Full Text] [Related]
8. Depletion of B lymphocytes in rheumatoid arthritis patients modifies IL-8-anti-IL-8 autoantibody network.
Keren Z; Braun-Moscovici Y; Markovits D; Rozin A; Nahir M; Balbir-Gurman A; Melamed D
Clin Immunol; 2009 Oct; 133(1):108-16. PubMed ID: 19632157
[TBL] [Abstract][Full Text] [Related]
9. B-cell targeted therapies in rheumatoid arthritis and systemic lupus erythematosus.
Eisenberg R; Albert D
Nat Clin Pract Rheumatol; 2006 Jan; 2(1):20-7. PubMed ID: 16932648
[TBL] [Abstract][Full Text] [Related]
10. [B cells as key contributors in determining the level of immune responses -B-cell-targeted therapy in patients with autoimmune diseases].
Kondo S; Akashi T; Katsuta H; Iwakiri R; Anzai K; Nagafuchi S; Niho Y; Harada M
Fukuoka Igaku Zasshi; 2005 Apr; 96(4):86-92. PubMed ID: 15991605
[TBL] [Abstract][Full Text] [Related]
11. B lymphocyte depletion in rheumatoid arthritis: targeting of CD20.
Edwards JC; Leandro MJ; Cambridge G
Curr Dir Autoimmun; 2005; 8():175-92. PubMed ID: 15564721
[TBL] [Abstract][Full Text] [Related]
12. B cells in rheumatoid arthritis.
Bugatti S; Codullo V; Caporali R; Montecucco C
Autoimmun Rev; 2007 Dec; 7(2):137-42. PubMed ID: 18035324
[TBL] [Abstract][Full Text] [Related]
13. Presence of a population of CD20+, CD38- B lymphocytes with defective proliferative responsiveness in the synovial compartment of patients with rheumatoid arthritis.
Reparon-Schuijt CC; van Esch WJ; van Kooten C; Ezendam NP; Levarht EW; Breedveld FC; Verweij CL
Arthritis Rheum; 2001 Sep; 44(9):2029-37. PubMed ID: 11592364
[TBL] [Abstract][Full Text] [Related]
14. Elevated expression of interleukin-7 receptor in inflamed joints mediates interleukin-7-induced immune activation in rheumatoid arthritis.
Hartgring SA; van Roon JA; Wenting-van Wijk M; Jacobs KM; Jahangier ZN; Willis CR; Bijlsma JW; Lafeber FP
Arthritis Rheum; 2009 Sep; 60(9):2595-605. PubMed ID: 19714586
[TBL] [Abstract][Full Text] [Related]
15. The autoimmune pathogenesis of rheumatoid arthritis: role of autoreactive T cells and new immunotherapies.
VanderBorght A; Geusens P; Raus J; Stinissen P
Semin Arthritis Rheum; 2001 Dec; 31(3):160-75. PubMed ID: 11740797
[TBL] [Abstract][Full Text] [Related]
16. [Pathology and progression of intra-articular inflammation in rheumatoid arthritis].
Geiler G
Verh Dtsch Ges Pathol; 1996; 80():46-57. PubMed ID: 9065054
[TBL] [Abstract][Full Text] [Related]
17. [Research progress on B cell surface molecules targeted therapy in rheumatoid arthritis].
Di W; Chang Y; Wu YJ; Wei W
Sheng Li Ke Xue Jin Zhan; 2011 Jun; 42(3):175-80. PubMed ID: 21932514
[TBL] [Abstract][Full Text] [Related]
18. Current aspects of anti-CD20 therapy in rheumatoid arthritis.
Jacobi AM; Dörner T
Curr Opin Pharmacol; 2010 Jun; 10(3):316-21. PubMed ID: 20189875
[TBL] [Abstract][Full Text] [Related]
19. [Intra-articular B-cells in the pathogenesis of rheumatoid arthritis].
Krenn V; Molitoris R; Sack U; Gross U; Vollmers HP; König A; Fork M; Berek C; Müller-Hermelink HK
Verh Dtsch Ges Pathol; 1996; 80():58-66. PubMed ID: 9065055
[TBL] [Abstract][Full Text] [Related]
20. Targeting B cells in immune-mediated inflammatory disease: a comprehensive review of mechanisms of action and identification of biomarkers.
Dörner T; Kinnman N; Tak PP
Pharmacol Ther; 2010 Mar; 125(3):464-75. PubMed ID: 20097226
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
